Neem (azadirachta indica) leaf preparation prevents leukocyte apoptosis mediated by cisplatin plus 5-fluorouracil treatment in swiss mice

Chemotherapy

Volumn 55, Issue 3, 2009, Pages 137-144

  Ghosh, Diptendu ^a   Bose, Anamika ^a   Haque, Enamul ^a   Baral, Rathindranath ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

5 Fluorouracil; Apoptosis; Cisplatin; Cytotoxicity; Leukopenia; Neem leaf preparation

Indexed keywords

ACETIC ACID; AZADIRACHTA INDICA EXTRACT; CISPLATIN; FILGASTIN; FLUGET; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; LACTATE DEHYDROGENASE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG; ZENOPLAST;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AZADIRACHTA INDICA; BLOOD CELL COUNT; CANCER GROWTH; CANCER INHIBITION; CIRCULATION; CONTROLLED STUDY; DRUG COST; DRUG CYTOTOXICITY; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; HEMOCYTOMETER; MOUSE; NATURAL KILLER CELL; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; SINGLE DRUG DOSE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; AZADIRACHTA; CISPLATIN; FLUOROURACIL; GRANULOCYTE COLONY-STIMULATING FACTOR; LEUKOCYTES; MICE; PLANT EXTRACTS; PLANT LEAVES;

EID: 63549085173     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000211558     Document Type: Article

References (19)

1. Ying H, Xiu Y, Ma F, Liu F, Xia M, Xu T: Protective effect of geranylgeranylacetone on cisplatin ototoxicity. Chemotherapy 2009; 55:1-5.
2. Manzano M, Bueno P, Rueda R, Ramirez-Tortosa CL, Prieto PA, Lopez-Pedrosa JM: Intestinal toxicity induced by 5-fluorouracil in pigs: a new preclinical model. Chemotherapy 2007; 53:344-355.
3. Yoshioka T, Sakayori M, Kato S, Chiba N, Miyazaki S, Nemoto K, Shibata H, Shimodaira H, Ohtsuka K, Kakudo Y, Sakata Y, Ishioka C: Dose escalation study of docetaxel and nedaplatin in patients with relapsed or refractory squamous cell carcinoma of the esophagus pretreated using cisplatin, 5-fluorouracil, and radiation. Int J Clin Oncol 2006; 11:454-460.
4. Guchelaar HJ, Vermes I, Koopmans RP, Reutelingsperger CP, Haanen C: Apoptosisand necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model. Cancer Chemother Pharmacol 1998; 42: 77-83.
5. Magné N, Fischel JL, Tiffon C, Formento P, Dubreuil A, Renée N, Formento JL, Francoual M, Ciccolini J, Etienne MC, Milano G: Molecular mechanisms underlying the interaction between ZD1839 ('Iressa') and cis-platin/5-fluorouracil. Br J Cancer. 2003; 89: 585-592.
6. Pizzo PA: Granulocytopenia and cancer therapy. Past problems, current solutions and future challenges. Cancer 1984; 54: 2649-2666.
7. Johnson EM, Crawford J: Hemotopoietic growth factors in the reduction of chemotherapeutic toxicity. Semin Oncol 1998; 25: 552-561.
8. Sung L, Nathan PC, Lange B, Beyene J, Buchanan GR: Prophylactic granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials. J Clin Oncol 2004; 22: 3350-3356.
9. Devereux S, Linch D: Haemopoietic growth factors. Q J Med 1990; 75:537-550.
10. Noda I, Fujieda S, Ohtsubo T, Tsuzuki H, Tanaka N, Sunaga H, Saito H: Granulocyte colony-stimulating factor enhances invasive potential of human head-and-neck carcinoma cell lines. Int J Cancer 1999; 80: 78-84.
11. D'Souza A, Jaiyesimi I, Trainor L, Venuturumili P: Granulocyte colony-stimulating factor administration: adverse events. Transfus Med Rev 2008; 22:280-290.
12. Baral RN, Chattopadhyay U: Neem (Azadirachta indica) leaf mediated immune activation causes prophylactic growth inhibition of murine Ehrlich carcinoma and B16 melanoma. Int Immunopharmacol 2004; 4:355-366.
13. Bose A, Haque E, Baral RN: Neem leaf preparation induces apoptosis of tumor cells by releasing cytotoxic cytokines from human peripheral blood mononuclear cells. Phytother Res 2007; 21: 914 - 9 2 0 .
14. Haque E, Mandal I, Pal S, Baral RN: Prophylactic dose of neem (Azadirachta indica) leaf preparation restricting murine tumor growth is nontoxic, hematostimulatory and immunostimulatory. Immunopharmacol Immunotoxicol 2006; 28: 33 -5 0.
15. Ghosh D, Bose A, Haque E, Baral RN: Pretreatment with neem (Azadirachta indica) leaf preparation in Swiss mice diminishes leukopenia and enhances anti-tumor activity of cyclophosphamide. Phytother Res 2006; 20:814-818.
16. Bose A, Baral RN: NK cellular cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L mediated endogenous production of IL-12. Human Immunol 2007; 68:823-831.
17. Hofer M, Vacek A, Holá J, Weiterová L, Streitová D: Peroral IMUNOR, a low molecular weight immunomodulator prepared from disintegrated and ultrafiltered leucocytes, enhances recovery from myelosuppression induced by Cisplatin or 5-Fluorouracil. Immunopharmacol Immunotoxicol 2006; 28:1-11.
18. Cianfarani F, Tommasi R, Failla CM, Viviano MT, Annessi G, Papi M, Zambruno G, Odorisio T: Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed. Br J Dermatol 2006; 154: 34-41.
19. Haque E, Baral RN: Neem (Azadirachta indica) leaf preparation induces prophylactic growth inhibition of murine Ehrlich carcinoma in Swiss and C57BL/6 mice by activation of NK cells and NK-T cells. Immunobiology 2006; 211: 721-731.